523 related articles for article (PubMed ID: 22001604)
21. AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges.
Kang L; Jin S; Wang J; Lv Z; Xin C; Tan C; Zhao M; Wang L; Liu J
J Control Release; 2023 Mar; 355():458-473. PubMed ID: 36736907
[TBL] [Abstract][Full Text] [Related]
22. The use of an adeno-associated viral vector for efficient bicistronic expression of two genes in the central nervous system.
Hutson TH; Kathe C; Menezes SC; Rooney MC; Bueler H; Moon LD
Methods Mol Biol; 2014; 1162():189-207. PubMed ID: 24838969
[TBL] [Abstract][Full Text] [Related]
23. Viral vectors in gene therapy.
Smith AE
Annu Rev Microbiol; 1995; 49():807-38. PubMed ID: 8561480
[TBL] [Abstract][Full Text] [Related]
24. Translational considerations for CNS gene therapy.
Ryan DA; Federoff HJ
Expert Opin Biol Ther; 2007 Mar; 7(3):305-18. PubMed ID: 17309323
[TBL] [Abstract][Full Text] [Related]
25. Current status of non-viral gene therapy for CNS disorders.
Jayant RD; Sosa D; Kaushik A; Atluri V; Vashist A; Tomitaka A; Nair M
Expert Opin Drug Deliv; 2016 Oct; 13(10):1433-45. PubMed ID: 27249310
[TBL] [Abstract][Full Text] [Related]
26. Virus-based gene delivery systems.
Mah C; Byrne BJ; Flotte TR
Clin Pharmacokinet; 2002; 41(12):901-11. PubMed ID: 12222993
[TBL] [Abstract][Full Text] [Related]
27. Gene delivery with viral vectors for cerebrovascular diseases.
Gan Y; Jing Z; Stetler RA; Cao G
Front Biosci (Elite Ed); 2013 Jan; 5(1):188-203. PubMed ID: 23276981
[TBL] [Abstract][Full Text] [Related]
28. Adeno-associated viral vectors as agents for gene delivery: application in disorders and trauma of the central nervous system.
Ruitenberg MJ; Eggers R; Boer GJ; Verhaagen J
Methods; 2002 Oct; 28(2):182-94. PubMed ID: 12413416
[TBL] [Abstract][Full Text] [Related]
29. AAV as a gene transfer vector for the treatment of neurological disorders: novel treatment thoughts for ALS.
Hester ME; Foust KD; Kaspar RW; Kaspar BK
Curr Gene Ther; 2009 Oct; 9(5):428-33. PubMed ID: 19860657
[TBL] [Abstract][Full Text] [Related]
30. Applications of gene therapy to the CNS.
Blömer U; Naldini L; Verma IM; Trono D; Gage FH
Hum Mol Genet; 1996; 5 Spec No():1397-404. PubMed ID: 8875243
[TBL] [Abstract][Full Text] [Related]
31. Cellular and molecular neurosurgery: pathways from concept to reality--part II: vector systems and delivery methodologies for gene therapy of the central nervous system.
Zlokovic BV; Apuzzo ML
Neurosurgery; 1997 Apr; 40(4):805-12; discussion 812-3. PubMed ID: 9092854
[TBL] [Abstract][Full Text] [Related]
32. Adeno-associated virus (AAV) gene therapy for neurological disease.
Weinberg MS; Samulski RJ; McCown TJ
Neuropharmacology; 2013 Jun; 69():82-8. PubMed ID: 22465202
[TBL] [Abstract][Full Text] [Related]
33. Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection.
Huang L; Wan J; Wu Y; Tian Y; Yao Y; Yao S; Ji X; Wang S; Su Z; Xu H
Life Sci; 2021 Apr; 270():119142. PubMed ID: 33524419
[TBL] [Abstract][Full Text] [Related]
34. Cancer gene therapy using adeno-associated virus vectors.
Park K; Kim WJ; Cho YH; Lee YI; Lee H; Jeong S; Cho ES; Chang SI; Moon SK; Kang BS; Kim YJ; Cho SH
Front Biosci; 2008 Jan; 13():2653-9. PubMed ID: 17981740
[TBL] [Abstract][Full Text] [Related]
35. Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions.
Lowenstein PR; Mandel RJ; Xiong WD; Kroeger K; Castro MG
Curr Gene Ther; 2007 Oct; 7(5):347-60. PubMed ID: 17979681
[TBL] [Abstract][Full Text] [Related]
36. Gene therapy: twenty-first century medicine.
Verma IM; Weitzman MD
Annu Rev Biochem; 2005; 74():711-38. PubMed ID: 15952901
[TBL] [Abstract][Full Text] [Related]
37. Brain-targeted delivery of neuroprotective survival gene minimizing hematopoietic cell contamination: implications for Parkinson's disease treatment.
Lee MH; Kang S; Um KH; Lee SW; Hwang H; Baek K; Choi JW
J Transl Med; 2024 Jan; 22(1):53. PubMed ID: 38218903
[TBL] [Abstract][Full Text] [Related]
38. Development and optimization of adeno-associated virus vector transfer into the central nervous system.
During MJ; Young D; Baer K; Lawlor P; Klugmann M
Methods Mol Med; 2003; 76():221-36. PubMed ID: 12526166
[No Abstract] [Full Text] [Related]
39. Herpes simplex virus type 1 amplicons and their hybrid virus partners, EBV, AAV, and retrovirus.
Oehmig A; Fraefel C; Breakefield XO; Ackermann M
Curr Gene Ther; 2004 Dec; 4(4):385-408. PubMed ID: 15578989
[TBL] [Abstract][Full Text] [Related]
40. Viral vector-mediated gene transfer for CNS disease.
Snyder BR; Boulis NM; Federici T
Expert Opin Biol Ther; 2010 Mar; 10(3):381-94. PubMed ID: 20132059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
